Big Pharma – Profite zu jedem Preis

big-pharma-–-profite-zu-jedem-preis

08-10-20 08:33:00,

Medikamente können Leben retten – die Pharmafirmen setzen die Preise so hoch wie möglich an.
© arte

Medikamente können Leben retten – die Pharmafirmen setzen die Preise so hoch wie möglich an.

Monique Ryser / 08. Okt 2020 –

Der Staat finanziert die Forschung, Pharmafirmen streichen die Gewinne ein und halten billige Medikamente bewusst zurück.

Der deutsch-französische TV-Sender arte hat mit dem Dokumentarfilm «Big Pharma – die Allmacht der Konzerne» die grossen Medikamentenproduzenten unter die Lupe genommen (auf YouTube abrufbar, in der Schweiz sind die Sendungen des deutsch-französischen Senders online gesperrt).

Eines der Beispiele betrifft direkt die Schweiz: Es geht um die Altersblindheit und die Medikamente Avastin und Lucentis. Avastin ist eigentlich ein Krebsmedikament, bei dem aber festgestellt wurde, dass es sehr gut gegen Altersblindheit (Altersbedingte Makula-Degeneration AMD) wirkt (in der Schweiz war das bereits 2011 ein Thema, wie Infosperber berichtete). Nur: Das von Roche hergestellte Avastin wurde bei den Behörden nie als Mittel gegen AMD angemeldet, weil der Konzern das Medikament Lucentis mit dem gleichen Wirkstoff auf dem Markt hat. Und dieses ist sagenhafte 13-mal teurer als Avastin. Wie CH Media berichtete, lässt sich das die Krankenversicherung Helsana nicht mehr bieten: Helsana-Chef Daniel Schmutz gab bekannt, dass Avastin vergütet werde, auch wenn es gegen das Gesetz verstosse. «Wir sparen für unsere Kunden jährlich rund eine Million Franken», wird er zitiert. Auf die ganze Schweiz berechnet gäbe es ein Sparpotential von jährlich 80 Millionen Franken, wenn auf das teurere Lucentis verzichtet würde.

Konkurrenten spannen zusammen und helfen sich gegenseitig

Avastin und Lucentis sind noch in einem anderen Zusammenhang ein gutes Beispiel für die Macht der Konzerne: Beide Medikamente werden von Roche produziert. In den USA vertreibt Roche auch beide Produkte selber. Ausserhalb der USA ist aber der grosse Schweizer Konkurrent Novartis – der selber zu 33 Prozent an Roche beteiligt ist – für den Vertrieb von Lucentis zuständig. Zwei Konzerne, die eigentlich im Wettbewerb stehen sollten, arbeiten hier zusammen und sichern sich gegenseitig die Marktmacht. Allerdings beginnen sich nicht nur Versicherer, wie in der Schweiz, sondern auch staatliche Wettbewerbsbehörden zu wehren: In Frankreich wurden die beiden Schweizer Firmen mit 444 Millionen Franken gebüsst. In Italien ist eine ähnliche Klage hängig. Novartis und Roche haben in beiden Ländern Berufung eingereicht.

Öffentliche Forschungsgelder, private Profite

Marcia Angell,

 » Lees verder

Big Pharma’s Man at FDA to Approve Coronavirus Vaccine Before Clinical Trials Completed? – Global Research

big-pharma’s-man-at-fda-to-approve-coronavirus-vaccine-before-clinical-trials-completed?-–-global-research

02-09-20 03:14:00,

At times, meds are more dangerous than diseases they’re supposed to protect against or cure.

Independent experts agree that all vaccines are hazardous to human health because they contain mercury, aluminum, formaldehyde, phenoxyethanol (antifreeze), and other toxins able to weaken and potentially destroy the human immune system.

Noted vaccine expert Dr. Viera Schiebner stressed that

“(t)here is no evidence whatsoever of the ability of vaccines to prevent any diseases.”

“To the contrary, there is a great wealth of evidence that they cause serious side effects.”

In her book titled “Vaccination 100 years of Orthodox Research,” she explained that vaccinations are biological weapons.

They can damage internal organs and leave children or adults vulnerable to severe autoimmune diseases – including diabetes, arthritis, hepatitis, multiple sclerosis, osteoporosis, polio and numerous others.

They’re dangerous and unreliable. Thousands of severe adverse reactions occur annually – including permanent disabilities, at times deaths.

Rushed to market coronavirus vaccines by Big Pharma will be especially hazardous and should be avoided to protect human health.

When available, a full COVID-19 vax treatment of millions of Americans would have a market potential dollar volume of around $150 billion of near-total profit, according to one estimate.

The global market potential is much greater — why the race is on to cash in big, with full support from policymakers in Washington.

There’s no need to be vaxxed when a known cure for COVID-19 already exists.

Big Pharma, establishment media and US policymakers are suppressing what everyone has a right to know because of a potential bonanza of profits once FDA-approved coronavirus vaccines are declared developed and ready for human use.

Hydroxychloroquine (HCQ) combined with either azithromycin or doxycycline and zinc are cheap, safe, and highly effective in curing the SARS-Cov-2 virus that causes COVID-19 when used early after infections are diagnosed.

Physicians using this protocol stress its effectiveness — why hazardous to human health vaccines aren’t needed and should be avoided.

Big Pharma’s FDA chief Stephen Hahn told the Financial Times (FT) that he’s “prepared to authorize a vaccine before phase three clinical trials (are) complete(d), as long as officials believed the benefits outweighed the risks (sic),” the broadsheet reported.

 » Lees verder

Watch Live: Big Pharma CEOs Testify Before Congress About “Pathway To A Vaccine”

watch-live:-big-pharma-ceos-testify-before-congress-about-“pathway-to-a-vaccine”

21-07-20 03:40:00,

With stocks continuing to power higher on elevated hopes for a vaccine by the end of the year, executives from five major drugmakers are testifying Tuesday before a House Energy and Commerce subcommittee panel. The executives will testify about their high-stakes efforts to develop a vaccine. Lawmakers are expected to grill them about plans to develop and distribute the vaccines.

The Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce is hosting the hearing. The House Committee on Energy and Commerce is led by Chairman Rep. Frank Pallone, and the subcommittee is led by Rep. Diana DeGette.

Watch live below:

Witnesses include:

  • Dr. Mene Pangalos Executive Vice President, BioPharmaceuticals R&D AstraZeneca
  • Dr. Macaya Douoguih Head of Clinical Development and Medical Affairs, Janssen Vaccines Johnson & Johnson
  • Dr. Julie Gerberding Executive Vice President and Chief Patient Officer Merck
  • Dr. Stephen Hoge President Moderna
  • Mr. John Young Chief Business Officer Pfizer

The tesimony is being delivered remotely via Cisco Webex.

 » Lees verder

Big pharma steered public money away from pandemic research and into projects promising profit – watchdog

big-pharma-steered-public-money-away-from-pandemic-research-and-into-projects-promising-profit-–-watchdog

25-05-20 10:35:00,

EU money intended for underfunded public-benefit research such as preparing for a pandemic has been diverted by the pharmaceutical industry into areas where it can make more money, according to a scathing new report.

Officials in Brussels wanted to co-fund research that would have ensured the European Union (EU) was better prepared for a pandemic akin to the one we are experiencing today. But their partners, the big pharmaceutical companies, rejected the proposal, ensuring that taxpayer money would go instead into studies with more potential for commercial application. In short big-pharma lobbyists were allowed to steer billions of euros of public funds as they saw fit, a damning new report claims.

The target of the criticism is the Innovative Medicines Initiative (IMI), a public-private partnership that was equally funded, between 2008 and 2020, by the European Federation of Pharmaceutical Industries and Associations (EFPIA) lobbying group and the European Commission to the tune of 5.3 billion euros (US$5.8 billion). The money is supposed to go to areas of “unmet medical or social need,” but, in practice, corporate priorities dominate the decision-making, according to the non-governmental organization Corporate Observatory Europe (COE).

“We were outraged to find evidence that the pharmaceutical industry lobby EFPIA not only did not consider funding biopreparedness (ie, being ready for epidemics such as the one caused by the new coronavirus, COVID-19) … but opposed it being included in IMI’s work when the possibility was raised by the European Commission in 2017,” a new COE report said.

Also on rt.com
Head of EU’s top science body quits after Covid-19 response plans get bogged down by Brussels bureaucracy

The rejected proposal would have directed money into refining computer simulations and the analysis of animal testing models, potentially speeding up regulatory approval of vaccines, according to the Guardian. But a spokeswoman for the IMI called the report “misleading”.

“The research proposed by the EC in the biopreparedness topic was small in scope,” she said. “IMI’s projects have contributed, directly or indirectly, to better prepare the research community for the current crisis, the Ebola+ programme or the ZAPI project.”

ZAPI,

 » Lees verder

Big Pharma Controlled FDA Approves Inadequately Tested Drug for COVID-19 – Global Research

big-pharma-controlled-fda-approves-inadequately-tested-drug-for-covid-19-–-global-research

03-05-20 04:41:00,

Big Pharma officials run the US Food and Drug Administration (FDA), its mandate focused on profit-making over human health and welfare.

Consumer advocate Ralph Nader earlier slammed “unrestrained drug industry havoc.”

Big Pharma “receives billions of dollars in tax credits for doing research and development that it should be doing anyway” — along with billions more in corporate welfare.

The Center for American Progress accused the industry of “reap(ing) profits while hurting everyday Americans.”

Exorbitant prices charged by Big Pharma far exceed their cost in other countries,, including developed ones.

In 2018, Americans spent $535 billion on prescription drugs, a 50% increase since 2010.

In her book titled “The Truth About the Drug Companies,” former New England Journal of Medicine editor Dr. Marcia Angell said the following:

“Only a small fraction of (Big Pharma’s) drugs are truly new. Most are simply ‘me too’ variations on older drugs.”

The industry is “primarily a marketing machine to sell drugs of dubious benefits, using its wealth and power to co-opt every institution that might stand in its way, including the US Congress, the (FDA), academic medical centers, and the medical profession itself.”

According to Katherine Greider in her book titled “The Big Fix: How the Pharmaceutical Industry Rips off American Consumers:”

“Other countries move to control prices and sharply limit advertising” — polar opposite how the US operates, competition not resulting in lower prices for consumers.

Industry analyst Tim Anderson earlier explained that “drug companies…looked at each other and said, ‘(n)one of us needs to compete on price if we just hold the line.’ ”

Despite US federal law requiring that FDA approved drugs must be “safe and effective,” Public Citizen’s Health Research Group revealed otherwise in three earlier books titled:

  • “Pills That Don’t Work”
  • “Over the Counter Pills That Don’t Work”
  • “Worst Pills, Best Pills: A Consumer’s Guide to Avoiding Drug-Induced Death or Illness”

Virtually all drugs have labels that warn of potential side effects that can be hazardous to human health.

Time and again, the FDA approves use of drugs prematurely. An estimated 100,000 American die annually from the toxic side effects of prescription drugs.

 » Lees verder